Septerna to Present at TD Cowen 45th Annual Health Care Conference

Company Overview - Septerna, Inc. is a biotechnology company focused on G protein-coupled receptor (GPCR) drug discovery using its proprietary Native Complex Platform™ [2] - The company aims to unlock the full potential of GPCR therapies and has developed a deep pipeline of oral small molecule product candidates [2] - Initial therapeutic areas of focus include endocrinology, immunology and inflammation, and metabolic diseases [2] Upcoming Events - Jeffrey Finer, M.D., Ph.D., CEO and Co-founder of Septerna, will present at the TD Cowen 45 Annual Health Care Conference on March 5, 2025, at 10:30 a.m. ET in Boston [1]